Citations

Showing 10 of 108104 citations.

Resection of an extensive thoracic arachnoid cyst via less-invasive targeted laminoplasties
Kerezoudis, Panagiotis , Rajjoub, Kenan , Shepherd, Daniel S., Bydon, Mohamad , Himes, Benjamin T., Rajjoub, Kenan R, Himes, Benjamin

Mayo Clinic

International Journal of Neuroscience | October 18, 2018 | Volume: 129 | Issue: 4 | Pages: 397-400

10.1080/00207454.2018.1538140 | PMID 30332907 Get It

The Stressed Executive: Sources and Predictors of Stress Among Participants in an Executive Health Program
Ganesh, Ravindra , Mahapatra, Saswati , Fuehrer, Debbie L., Folkert, Levi J, Jack, Whitney A, Jenkins, Sarah M. , Bauer, Brent A. , Wahner‐Roedler, Dietlind L. , Sood, Amit , Ganesh, Ravindra

Mayo Clinic

Global Advances in Health and Medicine | October 18, 2018 | Volume: 7 | Issue: No issue available | Pages: No page available

10.1177/2164956118806150 | PMID 30364454 Get It

Background Stress is highly prevalent in the U.S. society, especially in executives, and is a well-documented risk factor for a wide range of medical disorders. Knowledge of common sources of stress and predictive factors may help identify executives at risk of high stress and allow us to appropriately refer them for stress management treatment. Objective The primary aim of this study was to identify common sources of stress, predictors of high stress, and other correlates among executives. Methods This was a cross-sectional survey of executives who requested a stress management consult at our institution. We abstracted the data from a 14-item intake survey as well as from the patient interview. Results Of the 839 executives, 827 executives (98.6%) who were referred for individual stress management consults completed the stress-related questions of the survey; 51.3% of these executives reported having a high stress level. Study participants mostly struggled with the well-being measures of sleep, anxiety, energy level, and diet. The majority reported that their main stressor was work related (n = 540, 64.4%) followed by family related (n = 371, 44.2%), health related (n = 170, 20.3%), and work–life balance (n = 62, 7.4%). In unadjusted analysis, high stress was associated with younger age ( P = .006), lower quality-of-life scores ( P < .001), and less physical activity ( P < .001). In multivariable analyses, the strongest predictors for high stress level were younger age (odds ratios [OR] = 0.84, P = .045) and worse quality-of-life indicators such as anxiety (OR = 2.72, P < .001), diet (OR = 0.78, P = .02), and sleep (OR = 0.74, P < .003). Conclusion These findings suggest that executives with a high level of stress might be best helped through a multimodality stress management program. Our findings merit replication in larger studies and more definitive confirmation with prospective clinical trials.
Pregnancy, Preeclampsia, and Brain
Shawwa, Khaled , McDonnell, Niamh A., Garovic, Vesna D. , McDonnell, Niamh Anna

Mayo Clinic

Hypertension | October 17, 2018 | Volume: 72 | Issue: 6 | Pages: 1263-1265

10.1161/hypertensionaha.118.11493 | PMID 30571244 Get It

Adamantinoma of bone: Long‐term follow‐up of 46 consecutive patients
Houdek, Matthew T. , Sherman, Courtney E. , Inwards, Carrie Y., Wenger, Doris E. , Rose, Peter S. , Sim, Franklin H. , Houdek, Matthew T

Mayo Clinic

Journal of Surgical Oncology | October 17, 2018 | Volume: 118 | Issue: 7 | Pages: 1150-1154

10.1002/jso.25269 | PMID 30332521 Get It

BackgroundAdamantinomas are rare bone tumors, commonly affecting the tibia. Due to the rare nature of disease, previous studies are small or from multiple centers. The purpose of this study is to investigate outcomes of patients with adamantinoma treated in a single institution.MethodsForty‐six histological confirmed adamantinomas of the extremities were reviewed at our institution between 1939 and 2012. Follow‐up data included clinical and radiographical information focusing on complications, local recurrence, metastasis, and overall survival after the treatment. The mean follow‐up was 16 years (range 2‐42 years).ResultsThe most common location was the tibia (n = 31). Patients commonly presented with pain and swelling. The mean age was 24 years (7‐79 years). Thirty‐seven patients were treated with limb salvage. The 39% of patients required a reoperation. The 10‐year disease specific‐ and recurrence free survival was 92% and 72%, with three patients having a recurrence over 15 years postoperative. Older (> 20 years) patients and males were at increased risk of local recurrence (P < 0.05).ConclusionTreatment of adamantinoma of the long bone consists of limb‐salvage surgery. Male patients should be cautioned on their increased risk of disease recurrence, and advocate for continued surveillance of patients even greater than 15‐years postoperatively due to late tumor recurrence.
Adaptive method for multicriteria optimization of intensity‐modulated proton therapy
Kamal‐Sayed, Hisham, Tseung, H. Wan Chan, Herman, Michael , Beltran, Chris , Beltran, Chris J , Ma, J., Abdel‐Rehim, A.

Mayo Clinic

Medical Physics | October 17, 2018 | Volume: 45 | Issue: 12 | Pages: 5643-5652

10.1002/mp.13239 | PMID 30332515 Get It

PurposeProvide an adaptive multicriteria optimization (MCO) method for intensity‐modulated proton therapy (IMPT) utilizing GPU technology. Previously described limitations of MCO such as Pareto approximation and limitation on the number of objectives were addressed.MethodsThe treatment planning process for IMPT must account for multiple objectives, which requires extensive treatment planning resources. Often a large number of objectives (>10) are required. Hence the need for an MCO algorithm that can handle large number of objectives. The novelty of the MCO method presented here lies on the introduction of the adaptive weighting scheme that can generate a well‐distributed and dense representation of the Pareto surface for a large number of objectives in an efficient manner. In our approach the generated Pareto surface is constructed for a set of DVH objectives. The MCO algorithm is based on the augmented weighted Chebychev metric (AWCM) method with an adaptive weighting scheme. This scheme uses the differential evolution (DE) method to generate a set of well‐distributed Pareto points. The quality of the Pareto points’ distribution in the objective space was assessed quantitatively using the Pareto sampling metric. The MCO algorithm was developed to perform multiple parallel searches to achieve a rapid mapping of the Pareto surface, produce clinically deliverable plans, and was implemented on a GPU cluster. The MCO algorithm was tested on two clinical cases with 10 and 18 objectives. For each case one of the MCO‐generated plans was selected for comparison with the clinically generated plan. The MCO plan was randomly selected out of the set of MCO plans that had target coverage similar to the clinically generated plan and the same or better sparing of the organs at risk (OAR). Additionally, a validation study of the AWCM method vs the weighted sum method was performed.ResultsThe adaptive MCO algorithm generated Pareto points on the Pareto hypersurface in a fast (2–3 hr) and efficient manner for 2 cases with 10 and 18 objectives. The MCO algorithm generated a dense and well‐distributed set of Pareto points on the objective space, and was able to achieve minimization of the Pareto sampling metric. The selected MCO plan showed an improvement of the DVH objectives in comparison to the clinically optimized plan in both cases. For case one, the MCO plan showed a 48% reduction of the 50% dose to OARs and a 16% reduction of the 1% dose to OARs. For case 2, the MCO plan showed a 72% reduction of the 50% dose to OARs and a 42% reduction of the 1% dose to OARs. The comparison of AWCM to WS showed that the AWCM method has a dosimetric advantage over WS for both patient cases.ConclusionWe introduced an adaptive MCO algorithm for IMPT accelerated using GPUs. The algorithm is based on an adaptive method for generating Pareto plans in the objective space. We have shown that the algorithm can provide rapid and efficient mapping of the multicriteria Pareto surface with clinically deliverable plans.
Binding of Pneumocystis carinii to the lung epithelial cell receptor HSPA5 (GRP78)
Hebrink, Deanne, Kottom, Theodore J. , Hebrink, Deanne M, Limper, Andrew H.

Mayo Clinic

Journal of Medical Microbiology | October 17, 2018 | Volume: 67 | Issue: 12 | Pages: 1772-1777

10.1099/jmm.0.000864 | PMID 30328808 Get It

Small‐spot intensity‐modulated proton therapy and volumetric‐modulated arc therapies for patients with locally advanced non‐small‐cell lung cancer: A dosimetric comparative study
Liu, Chenbin , Shan, Jie , Daniels, T.B., Rule, William G., Lara, Pedro R., Korte, Shawn M., Shen, Jiajian , Ding, Xiaoning, Daniels, Thomas B, Schild, Steven E. , Bues, Martin , Shen, Jiajian , Sio, Terence T. , Deng, Wei, Shan, Jie, Lara, Pedro R., Liu, Wei

Mayo Clinic

Journal of Applied Clinical Medical Physics | October 17, 2018 | Volume: 19 | Issue: 6 | Pages: 140-148

10.1002/acm2.12459 | PMID 30328674 Get It

AbstractPurposeTo compare dosimetric performance of volumetric‐modulated arc therapy (VMAT) and small‐spot intensity‐modulated proton therapy for stage III non‐small‐cell lung cancer (NSCLC).Methods and MaterialsA total of 24 NSCLC patients were retrospectively reviewed; 12 patients received intensity‐modulated proton therapy (IMPT) and the remaining 12 received VMAT. Both plans were generated by delivering prescription doses to clinical target volumes (CTV) on averaged 4D‐CTs. The dose‐volume‐histograms (DVH) band method was used to quantify plan robustness. Software was developed to evaluate interplay effects with randomized starting phases of each field per fraction. DVH indices were compared using Wilcoxon rank sum test.ResultsCompared with VMAT, IMPT delivered significantly lower cord Dmax, heart Dmean, and lung V5 Gy[RBE] with comparable CTV dose homogeneity, and protection of other OARs. In terms of plan robustness, the IMPT plans were statistically better than VMAT plans in heart Dmean, but were statistically worse in CTV dose coverage, cord Dmax, lung Dmean, and V5 Gy[RBE]. Other DVH indices were comparable. The IMPT plans still met the standard clinical requirements with interplay effects considered.ConclusionsSmall‐spot IMPT improves cord, heart, and lung sparing compared to VMAT and achieves clinically acceptable plan robustness at least for the patients included in this study with motion amplitude less than 11 mm. Our study supports the usage of IMPT to treat some lung cancer patients.
Faculty Opinions recommendation of Clear up this stem-cell mess.
Evans, Christopher H.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | October 17, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.734075040.793551494 Get It

Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management
Gertz, Morie A. , Gertz, Morie A

Mayo Clinic

American Journal of Hematology | October 17, 2018 | Volume: 94 | Issue: 2 | Pages: 266-276

10.1002/ajh.25292 | PMID 30328142 Get It

Disease OverviewWaldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include anemia, thrombocytopenia, hepatosplenomegaly, lymphadenopathy, and rarely hyperviscosity.DiagnosisPresence of IgM monoclonal protein associated with ≥10% clonal lymphoplasmacytic cells in bone marrow confirms the diagnosis. The L265P mutation in MYD88 is detectable in >90% of patients and is found in the majority of IgM monoclonal gammopathy of undetermined significance patients.Risk StratificationAge, hemoglobin level, platelet count, β2 microglobulin, and monoclonal IgM concentrations are characteristics that are predictive of outcomes.Risk‐Adapted TherapyNot all patients who fulfill WM criteria require therapy; these patients can be observed until symptoms develop. Rituximab‐monotherapy is inferior to regimens that combine it with bendamustine, an alkylating agent, a proteosome inhibitor, or ibrutinib. Purine nucleoside analogs are active but usage is declining for less toxic alternatives. The preferred Mayo Clinic induction is rituximab and bendamustine. Potential for stem cell transplantation should be considered in selected younger patients.Management of Refractory DiseaseBortezomib, fludarabine, thalidomide, everolimus, ibrutinib, carfilzomib, lenalidomide, and bendamustine have all been shown to have activity in relapsed WM. Given WM's natural history, reduction of therapy toxicity is an important part of treatment selection.
Clinical performance of intentionally tilted implants versus axially positioned implants: A systematic review
Lin, Wei‐Shao , Eckert, Steven E

Mayo Clinic

Clinical Oral Implants Research | October 17, 2018 | Volume: 29 | Issue: S16 | Pages: 78-105

10.1111/clr.13294 | PMID 30328193 Get It

AbstractObjectivesThe aim of this review was to determine the clinical performance of dental implants that are intentionally tilted when compared with implants that are placed following the long axis of the residual alveolar ridge.Materials and methodsA systematic review of the scientific literature using a predefined research question (PICO) and search strategy was undertaken. This search included five electronic databases. Two independent reviewers examined electronic databases and performed a manual review following search strategy to accomplish the item generation and reduction. Included articles were evaluated to determine the level of evidence. Data were extracted only from level I and level II studies, based on the Oxford Centre for Evidence‐based Medicine—Levels of Evidence (March 2009). If included studies were homogeneous in nature, data were to be accumulated. However, if included studies were heterogeneous in nature, only descriptive data would be reviewed and analyzed.ResultsA total of 811 articles were identified through the PICO question and search strategy. Detailed review of the abstracts and articles resulted in further item reduction, and 46 articles were included for full‐text review. A total of 42 articles were then selected for inclusion in the systematic review. The identified articles included two level I and 20 level II studies. In addition, 15 level IV, one gray literature, and four previous systematic reviews with meta‐analyses were also used in the study. The extracted data from the included studies demonstrated heterogeneity that prevented quantitative assessment, and only one level II study directly compared tilted and axially placed implants. Assessment of the descriptive data demonstrated no differences in implant survival, marginal bone loss, prosthesis survival, or patient‐reported outcome measures (PROMs) whether implants are placed axially or with intentional inclination of the coronal aspect of the implant toward the distal aspect of edentulous jaws.ConclusionsBased upon the systematic review of the literature, an analysis of the descriptive data suggested no differences in clinical performance between implants that are placed in an axial position relative to the residual alveolar ridge when compared with implants that are intentionally tilted toward the distal aspect of edentulous jaws.